MyOme

My Genome. My Health. MyOme.

San Francisco, United States · Founded 2017 · $23.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Website
myome.com
Total Funding
$23.0M
Last Round
$23.0M Corporate RoundDec 2025
Rounds
3

About

MyOme is a clinical whole genome analysis platform helping patients and providers understand genetic risk for inherited diseases. Using whole genome sequencing and proprietary bioinformatics, MyOme produces actionable reports covering rare disease, medication response, and polygenic risk. Founded in 2017 and based in San Francisco.

Summary

MyOme is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $23.0M in total across 3 rounds, most recently a $23.0M Corporate Round round in Dec 2025. Investors include Illumina Ventures, Healthcare Venture Partners and HOF Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundStrategic InvestmentDec 2025

Sign up to see all 3 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MyOme on Indexed.vc
<a href="https://indexed.vc/companies/myome"><img src="https://indexed.vc/api/badge/company/myome" alt="MyOme on Indexed.vc" width="260" height="76" /></a>